Literature DB >> 18280792

Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells.

Chaorui Tian1, Xueli Yuan, Jessamyn Bagley, Bruce R Blazar, Mohamed H Sayegh, John Iacomini.   

Abstract

The observation that bone marrow derived hematopoietic cells are potent inducers of tolerance has generated interest in trying to establish transplantation tolerance by inducing a state of hematopoietic chimerism through allogeneic bone marrow transplantation. However, this approach is associated with serious complications that limit its utility for tolerance induction. Here we describe the development of a novel approach that allows for tolerance induction without the need for an allogeneic bone marrow transplant by combining non-myeloablative host conditioning with delivery of donor alloantigen by adoptively transferred T cells. CBA/Ca mice were administered 2.5 Gy whole body irradiation (WBI). The following day the mice received K(b) disparate T cells from MHC class I transgenic CBK donor mice, as well as rapamycin on days 0-13 and anti-CD40L monoclonal antibody on days 0-5, 8, 11 and 14 relative to T cell transfer. Mice treated using this approach were rendered specifically tolerant to CBK skin allografts through a mechanism involving central and peripheral deletion of alloreactive T cells. These data suggest robust tolerance can be established without the need for bone marrow transplantation using clinically relevant non-myeloablative conditioning combined with antigen delivery by T cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18280792      PMCID: PMC2430039          DOI: 10.1016/j.clim.2008.01.005

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  38 in total

1.  Human CD4+ T cells mediate rejection of porcine xenografts.

Authors:  T Friedman; A Shimizu; R N Smith; R B Colvin; J D Seebach; D H Sachs; J Iacomini
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

3.  Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection.

Authors:  N D Jones; S E Turvey; A Van Maurik; M Hara; C I Kingsley; C H Smith; A L Mellor; P J Morris; K J Wood
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

Review 4.  HLA matching for kidney transplantation.

Authors:  Steve Takemoto; Friedrich K Port; Frans H J Claas; Rene J Duquesnoy
Journal:  Hum Immunol       Date:  2004-12       Impact factor: 2.850

5.  Each of the two productive T cell receptor alpha-gene rearrangements found in both the A10 and BM 3.3 T cell clones give rise to an alpha chain which can contribute to the constitution of a surface-expressed alpha beta dimer.

Authors:  D Couez; M Malissen; M Buferne; A M Schmitt-Verhulst; B Malissen
Journal:  Int Immunol       Date:  1991-07       Impact factor: 4.823

6.  Homeostatic expansion permits T cells to re-enter the thymus and deliver antigen in a tolerogenic fashion.

Authors:  C Tian; J Bagley; J Iacomini
Journal:  Am J Transplant       Date:  2007-08       Impact factor: 8.086

7.  T cells can present antigens such as HIV gp120 targeted to their own surface molecules.

Authors:  A Lanzavecchia; E Roosnek; T Gregory; P Berman; S Abrignani
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

Review 8.  HLA compatibility and organ transplant survival. Collaborative Transplant Study.

Authors:  G Opelz; T Wujciak; B Döhler; S Scherer; J Mytilineos
Journal:  Rev Immunogenet       Date:  1999

9.  Induction of central tolerance by mature T cells.

Authors:  Chaorui Tian; Jessamyn Bagley; Daron Forman; John Iacomini
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

10.  Induction of tolerance to self MHC class I molecules expressed under the control of milk protein or beta-globin gene promoters.

Authors:  A M Sponaas; P D Tomlinson; J Antoniou; N Auphan; C Langlet; B Malissen; A M Schmitt-Verhulst; A L Mellor
Journal:  Int Immunol       Date:  1994-02       Impact factor: 4.823

View more
  4 in total

1.  Induction of transplantation tolerance to fully mismatched cardiac allografts by T cell mediated delivery of alloantigen.

Authors:  Chaorui Tian; Xueli Yuan; Peter T Jindra; Jessamyn Bagley; Mohamed H Sayegh; John Iacomini
Journal:  Clin Immunol       Date:  2010-05-08       Impact factor: 3.969

Review 2.  Transplantation tolerance through mixed chimerism.

Authors:  Nina Pilat; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2010-08-31       Impact factor: 28.314

3.  Tolerance induction in experimental autoimmune encephalomyelitis using non-myeloablative hematopoietic gene therapy with autoantigen.

Authors:  Herena Eixarch; Carmen Espejo; Alba Gómez; María José Mansilla; Mireia Castillo; Alexander Mildner; Francisco Vidal; Ramón Gimeno; Marco Prinz; Xavier Montalban; Jordi Barquinero
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

4.  Tolerance to MHC class II disparate allografts through genetic modification of bone marrow.

Authors:  P T Jindra; S Tripathi; C Tian; J Iacomini; J Bagley
Journal:  Gene Ther       Date:  2012-07-26       Impact factor: 5.250

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.